Combining EBRT and HDR-BT in high-risk prostate cancer: an effective and safe experience

被引：0
|
作者：
Candini, D. [1 ]
Lopez-Campos, F. [1 ]
Munoz, T. [1 ]
Martin, M. [1 ]
Vallejo, C. [1 ]
Hervas, A. [1 ]
机构：
[1] Hosp Ramon & Cajal, Radiat Oncol, Madrid, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)31847-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1538
引用
收藏
页码：S831 / S831
页数：1
相关论文
共 50 条
  • [1] APOPTOSIS AND SENESCENCE IN LOCALIZED PROSTATE CANCER TISSUES TREATED WITH HDR-BT BOOST WITH RADIOTHERAPY (EBRT) AND ADT
    Chebra, Imen
    Carignan, Damien
    Perigny, Martine
    Martin, Andre-Guy
    Foster, William
    Vigneault, Eric
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S33 - S33
  • [2] Apoptosis and Senescence in Localized Prostate Cancer Tissues Treated With HDR-BT Boost With Radiotherapy (EBRT) and ADT
    Chebra, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E258 - E258
  • [3] HIGH-DOSE-RATE BRACHYTHERAPY (HDR-BT) COMBINED WITH EXTERNAL BEAM RADIATION THERAPY (EBRT) IN PATIENTS WITH PROSTATE CANCER
    Inomata, T.
    Shimbo, T.
    Takahashi, M.
    Uesugi, Y.
    Azuma, H.
    Katsuoka, Y.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S327 - S327
  • [4] Late toxicity after single dose HDR-BT and EBRT for prostate cancer: clinical-dosimetric predictors
    Buchser, D.
    Casquero, F.
    Espinosa, J. M.
    Perez, F.
    Minguez, P.
    Martinez-Indart, L.
    Suarez, F.
    Gonzalez, A.
    Cacicedo, J.
    San Miguel, I.
    Bilbao, P.
    Gomez-Iturriaga, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1191 - S1191
  • [5] Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients
    Martell, K.
    Mendez, L. C.
    Chung, H. T.
    Tseng, C. L.
    Alayed, Y.
    Cheung, P.
    Liu, S.
    Vesprini, D.
    Chu, W.
    Wronski, M.
    Szumacher, E.
    Ravi, A.
    Loblaw, A.
    Morton, G.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 149 - 155
  • [6] External beam (EBRT) and HDR brachytherapy (BT) in prostate cancer: impact of EBRT volume
    Tharmalingam, H.
    Tsang, Y.
    Choudhury, A.
    Hoskin, P.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S146 - S147
  • [7] Ten-year overall and prostate cancer (PCa)-specific mortality in high-risk patients after high-dose-rate brachytherapy combined with external beam radiation therapy (HDR-BT/EBRT) compared with EBRT alone.
    Wedde, Trude Baastad
    Fossa, Sophie
    Brabrand, Sigmund
    Kaasa, Stein
    Russnes, Kjell Magne
    Hellebust, Taran Poulsen
    Tafjord, Gunnar
    Lilleby, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] MRI guided focal primary and (secondary) salvage HDR-BT in prostate cancer patients seems safe
    Maenhout, M.
    Moerland, M. A.
    Van Vliet-van den Ende, K. M.
    Schokker, R. I.
    de Battisti, M. Borot
    Peters, M.
    Van Vulpen, M.
    van Zyp, J. R. N. Van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S16 - S17
  • [9] PSA-KINETICS FOLLOWING EXTERNAL BEAM RADIOTHERAPY (EBRT), TEMPORARY INTERSTITIAL BRACHYTHERAPY AS A BOOST TO EBRT (HDR-BT) AND PERMANENT INTERSTITIAL BRACHYTHERAPY AS BRACHYTHERAPY (LDR-BT) FOR PROSTATE CANCER
    Pinkawa, M.
    Holy, R.
    Piroth, M.
    Klotz, J.
    Borchers, H.
    Eble, M.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S54 - S54
  • [10] Survial Endpoints Comparing HDR BT Boost To EBRT Boost For High/Intermediate-Risk Prostate Cancer.
    Rodriguez Villalba, S.
    Richart Sancho, J.
    Perez-Calatayud, J.
    Lago Martin, J. D.
    Santos Ortega, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1253 - S1254
12345